Pruksakorn Dumnoensun, Kongthavonskul Jatupon, Teeyakasem Pimpisa, Phanphaisarn Areerak, Chaiyawat Parunya, Klangjorhor Jeerawan, Arpornchayanon Olarn
Orthopedic Laboratory and Research Network (OLARN), Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Biomedical Engineering Institute, Chiang Mai University, Thailand.
J Bone Oncol. 2018 Dec 10;14:100210. doi: 10.1016/j.jbo.2018.100210. eCollection 2019 Feb.
To assess the failure rate and mode failure of high-grade osteosarcoma patients who received extracorporeal irradiation and re-implantation (ECIR) in extremities.
For the cohort study, patients who had received ECIR at a single institution between January 1996 and December 2014 were retrospectively evaluated. Characteristics of failure and time to failure were recorded and analyzed. In addition, a systematically search of published literatures regarding the use of ECIR for osteosarcoma was conducted. Failure rates and modes of failure were determined from the pooled data.
In the cohort study, the overall reconstruction failure was 46% (23 of 50 cases) of which 6% were due to mechanical failure, and 40% were due to non-mechanical failure. In the systematic review, 164 cases reached the criteria for analysis (50 diaphysis, 97 osteochondral of lower extremity, 6 knee resection, and 11 proximal humerus resection). Among those cases, overall failure rate was 29.9% (49 of 164 cases) of which 7.9% were due to mechanical failure, and 22.0% to non-mechanical failure. Diaphyseal resection with intercalary re-implantation had a significantly lower failure rate than osteochondral reconstruction of lower extremity (OR: 2.7, and knee extra-articular resection osteochondral re-implantation OR: 10.5.
Diaphyseal resection and extracorporeal irradiation of intercalary re-implantation offer the most promising outcome among other type of reconstructions. Availability of graft, fewer structural complications, and biological permanence are advantages of this reconstruction method.
评估接受肢体体外照射及再植入(ECIR)的高级别骨肉瘤患者的失败率及失败模式。
对于该队列研究,对1996年1月至2014年12月期间在单一机构接受ECIR的患者进行回顾性评估。记录并分析失败特征及失败时间。此外,系统检索已发表的关于ECIR用于骨肉瘤的文献。从汇总数据中确定失败率及失败模式。
在队列研究中,总体重建失败率为46%(50例中的23例),其中6%为机械性失败,40%为非机械性失败。在系统评价中,164例达到分析标准(50例骨干、97例下肢骨软骨、6例膝关节切除、11例肱骨近端切除)。在这些病例中,总体失败率为29.9%(164例中的49例),其中7.9%为机械性失败,22.0%为非机械性失败。骨干切除并植入中间段再植入的失败率显著低于下肢骨软骨重建(比值比:2.7),膝关节关节外切除骨软骨再植入的比值比为10.5。
骨干切除及中间段再植入的体外照射在其他类型重建中提供了最有前景的结果。移植物的可用性、较少的结构并发症及生物学永久性是这种重建方法的优点。